Related references
Note: Only part of the references are listed.LINC00311 is overexpressed in ankylosing spondylitis and predict treatment outcomes and recurrence
Hongfa Zhong et al.
BMC MUSCULOSKELETAL DISORDERS (2019)
LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis
Xiaowen Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Participation of tumor suppressors long non-coding RNA MEG3, microRNA-377 and PTEN in glioma cell invasion and migration
Dong Wang et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Vibrio cholerae derived outer membrane vesicles modulate the inflammatory response of human intestinal epithelial cells by inducing microRNA-146a
Aziz Bitar et al.
SCIENTIFIC REPORTS (2019)
Maternally expressed gene 3 (MEG3): A tumor suppressor long non coding RNA
Soudeh Ghafouri-Fard et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Identification of the key genes and long non-coding RNAs in ankylosing spondylitis using RNA sequencing
Zhengkuan Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)
lncRNA MEG3 is downregulated in ankylosing spondylitis and associated with disease activity, hospitalization time and disease duration
Wei Liu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
MicroRNA-146a knockdown suppresses the progression of ankylosing spondylitis by targeting dickkopf 1
Guijuan Di et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Downregulation of lncRNA TUG1 is involved in ankylosing spondylitis and is related to disease activity and course of treatment
Xiaoyong Lan et al.
BIOSCIENCE TRENDS (2018)
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort
Christoph Molnar et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Long noncoding RNAs: lincs between human health and disease
Zhi Hao Kwok et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
Differential Expression Profiles of Long Noncoding RNA and mRNA of Osteogenically Differentiated Mesenchymal Stem Cells in Ankylosing Spondylitis
Zhongyu Xie et al.
JOURNAL OF RHEUMATOLOGY (2016)
Identification of Serum miR-146a and miR-155 as Novel Noninvasive Complementary Biomarkers for Ankylosing Spondylitis
Bang-ping Qian et al.
SPINE (2016)
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Dominique Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Long noncoding RNAs in human disease: emerging mechanisms and therapeutic strategies
Sebastien Lalevee et al.
EPIGENOMICS (2015)
Association between Ankylosing Spondylitis and the miR-146a and miR-499 Polymorphisms
Hui Ying Xu et al.
PLOS ONE (2015)
TNF-alpha inhibitors for ankylosing spondylitis
Lara J. Maxwell et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
The classification and diagnostic criteria of ankylosing spondylitis
Siba P. Raychaudhuri et al.
JOURNAL OF AUTOIMMUNITY (2014)
The multilayered complexity of ceRNA crosstalk and competition
Yvonne Tay et al.
NATURE (2014)
MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas
Vladimir Balik et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Increased mortality in ankylosing spondylitis is related to disease activity
Gunnstein Bakland et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Maternally Expressed Gene 3, an Imprinted Noncoding RNA Gene, Is Associated with Meningioma Pathogenesis and Progression
Xun Zhang et al.
CANCER RESEARCH (2010)
Critical appraisal of assessment of structural damage in ankylosing spondylitis
Joachim Sieper et al.
ARTHRITIS AND RHEUMATISM (2008)
NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses
Konstantin D. Taganov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Share Paper
